Ole Suhr

Contact

Works at

Affiliated as professor at Department of Public Health and Clinical Medicine

Byggnad 1A, plan 4, målpunkt B41, Norrlands universitetssjukhus Umeå universitet, 901 85 Umeå

Amyloid fibril composition type is consistent over time in patients with Val30Met (p. Val50Met) transthyretin amyloidosis

PLOS ONE, Public Library of Science 2022, Vol. 17, (3)

Anan, Intissar; Suhr, Ole B.; Liszewska, Katarzyna; et al.

Transthyretin cardiac amyloidosis in continental Western Europe: An insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)

European Heart Journal, Oxford University Press 2022, Vol. 43, (5) : 391-400

Damy, Thibaud; Kristen, Arnt V; Suhr, Ole B.; et al.

Cerebellar and Cerebral Amyloid Visualized by [18F]flutemetamol PET in Long-Term Hereditary V30M (p.V50M) Transthyretin Amyloidosis Survivors

Frontiers in Neurology, Frontiers Media S.A. 2022, Vol. 13

Unéus, Erica Irene; Wilhelmsson, Christer; Bäckström, David; et al.

Hereditary transthyretin amyloidosis - from symptomatic to curative treatment?: [Ärftlig transtyretinamyloidos – från lindring till potentiell bot]

Läkartidningen, Stockholm: Sveriges Läkarförbund 2022, Vol. 119 : 26-30

Wixner, Jonas; Anan, Intissar; Pilebro, Björn; et al.

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

Journal of Neurology, Springer Berlin/Heidelberg 2021, Vol. 268, (6) : 2109-2122

Adams, David; Ando, Yukio; Beirão, João Melo; et al.

Transthyretin amyloid deposits in lumbar spinal stenosis and assessment of signs of systemic amyloidosis

Journal of Internal Medicine, John Wiley & Sons 2021, Vol. 289, (6) : 895-905

Eldhagen, P.; Berg, S.; Lund, L. H.; et al.

Cardiac transthyretin amyloidosis ^99mTc-DPD SPECTcorrelates with strain echocardiography and biomarkers

European Journal of Nuclear Medicine and Molecular Imaging, Springer 2021, Vol. 48 : 1822-1832

Löfbacka, Viktor; Axelsson, Jan; Pilebro, Björn; et al.

Combining ECG and echocardiography to identify transthyretin cardiac amyloidosis in heart failure

Clinical Physiology and Functional Imaging, John Wiley & Sons 2021, Vol. 41, (5) : 408-416

Löfbacka, Viktor; Suhr, Ole B.; Pilebro, Björn; et al.

A human antibody selective for transthyretin amyloid removes cardiac amyloid through phagocytic immune cells

Nature Communications, Nature Publishing Group 2021, Vol. 12, (1)

Michalon, Aubin; Hagenbuch, Andreas; Huy, Christian; et al.

Recommendations for the diagnosis and management of transthyretin amyloidosis with gastrointestinal manifestations

European Journal of Gastroenterology and Hepathology, Lippincott Williams & Wilkins 2021, Vol. 33, (5) : 613-622

Nakov, Radislav; Suhr, Ole B.; Ianiro, Gianluca; et al.

A phase II, open-label, extension study of long-term patisiran treatment in patients with hereditary transthyretin-mediated (hATTR) amyloidosis

Orphanet Journal of Rare Diseases, BioMed Central (BMC) 2020, Vol. 15, (1)

Coelho, Teresa; Adams, David; Conceicao, Isabel; et al.

Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner

BMC Family Practice, BMC 2020, Vol. 21, (1)

Gertz, Morie; Adams, David; Ando, Yukio; et al.

Identifying Mixed Phenotype: Evaluating the Presence of Polyneuropathy in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Cardiomyopathy

Neurology, Lippincott Williams & Wilkins 2020, Vol. 94, (15)

Merkel, Madeline; Grogan, Martha; Hawkins, Philip N.; et al.

Quantification of cardiac amyloid with [¹⁸F]Flutemetamol in patients with V30M hereditary transthyretin amyloidosis

Amyloid: Journal of Protein Folding Disorders, Taylor & Francis 2020, Vol. 27, (3) : 191-199

Möckelind, Sofia; Axelsson, Jan; Pilebro, Björn; et al.

Irritable bowel syndrome-like symptoms in treated microscopic colitis patients compared with controls: a cross-sectional study

Gastroenterology Report, Oxford University Press 2020, Vol. 8, (5) : 374-380

Pagoldh, Jenny; Lundgren, David; Suhr, Ole B.; et al.

Abdominal fat pad biopsies exhibit good diagnostic accuracy in patients with suspected transthyretin amyloidosis

Orphanet Journal of Rare Diseases, BioMed Central (BMC) 2020, Vol. 15, (1)

Paulsson Rokke, Hedvig; Sadat Gousheh, Nima; Westermark, Per; et al.

Impact of Patisiran on Overall Health Status in hATTR Amyloidosis: Results from the APOLLO Trial

Neurology, LIPPINCOTT WILLIAMS & WILKINS 2019, Vol. 92, (15)

Ajroud-Driss, Senda; Adams, David; Coelho, Teresa; et al.

Identifying Mixed Phenotype: Evaluating the Presence of Polyneuropathy in Patients with Hereditary Transthyretin-Mediated Amyloidosis with Cardiomyopathy

Journal of Cardiac Failure, Vol. 25, (8) : S9-S10

Grogan, Martha; Hawkins, Philip N.; Kristen, Arnt V.; et al.

Prevalence of transthyretin cardiac amyloidosis in a community-based heart failure population

European Heart Journal, Oxford University Press 2019, Vol. 40 : 132-132

Lindmark, Krister; Pilebro, Björn; Solekrans, L.; et al.

Diagnosis and treatment of gastrointestinal dysfunction in hereditary TTR amyloidosis

Clinical Autonomic Research, Springer 2019, Vol. 29 : 55-63

Obici, Laura; Suhr, Ole B.

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study

Circulation, Lippincott Williams & Wilkins 2019, Vol. 139, (4) : 431-443

Solomon, Scott D.; Adams, David; Kristen, Arnt; et al.

Response: concerning “late early and late onset” ATTR Val30Met patients

Amyloid: Journal of Protein Folding Disorders, Taylor & Francis 2019, Vol. 26, (4) : 250-250

Suhr, Ole B.

Commentary to Isabel Conceicao et al. early diagnosis through targeted follow-up of identified carriers of TTR gene mutations

Amyloid: Journal of Protein Folding Disorders, TAYLOR & FRANCIS LTD 2019, Vol. 26, (1) : 1-2

Suhr, Ole B.

Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families

PLOS ONE, Public Library Science 2019, Vol. 14, (2)

Suhr, Ole Bernt; Wixner, Jonas; Anan, Intissar; et al.

Visualisation of amyloid deposition within the brain of long-term hereditary transthyretin amyloidosis survivors by 18F-flutemetamol positron emission tomography

European Journal of Neurology, John Wiley & Sons 2019, Vol. 26, (S1) : 287-287

Unéus, Erica; Wilhelmsson, Christer; Suhr, Ole; et al.

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

New England Journal of Medicine, Massachusetts Medical Society 2018, Vol. 379, (1) : 11-21

Adams, D.; Gonzalez-Duarte, A.; O'Riordan, W. D.; et al.

Impact of Patisiran on overall health status in hATTR amyloidosis: Results from the APOLLO trial

Journal of the peripheral nervous system, John Wiley & Sons 2018, Vol. 23, (4) : 272-273

Ajroud-Driss, Senda; Adams, David; Coelho, Teresa; et al.

Right ventricular involvement in transthyretin amyloidosis

Amyloid: Journal of Protein Folding Disorders, Taylor & Francis 2018, Vol. 25, (3) : 160-166

Arvidsson, Sandra; Henein, Michael Y; Wikström, Gerhard; et al.

Longitudinal changes in mNIS+7 are associated with changes in ambulatory status in hereditary transthyretin-mediated amyloidosis

Journal of the peripheral nervous system, John Wiley & Sons 2018, Vol. 23, (4) : 354-355

Coelho, Teresa; Suhr, Ole; Quan, Dianna; et al.

Neuropathy progression in patients with hATTR amyloidosis: Analysis of the APOLLO placebo arm

Journal of the peripheral nervous system, John Wiley & Sons 2018, Vol. 23, (4) : 274-275

Dyck, P. James; Adams, David; Coelho, Teresa; et al.

Changes in neuropathy stage in patients with hATTR amyloidosis following patisiran treatment: Analysis from APOLLO

Journal of the peripheral nervous system, John Wiley & Sons 2018, Vol. 23, (4) : 400-400

Gonzalez-Duarte, Alejandra; Adams, David; O'Riordan, William; et al.

Variation of Penetrance estimates in a wide spectrum of TTR-FAP families: implication for management of carriers

Neurology, Lippincott Williams & Wilkins 2018, Vol. 90

Gorram, Farida; Olsson, Malin; Alarcon, Flora; et al.

Reduced left atrial myocardial deformation irrespective of cavity size: a potential cause for atrial arrhythmia in hereditary transthyretin amyloidosis

Amyloid: Journal of Protein Folding Disorders, Taylor & Francis 2018, Vol. 25, (1) : 46-53

Henein, Michael Y.; Suhr, Ole B.; Arvidsson, Sandra; et al.

Positron emission tomography (PET) utilizing Pittsburgh compound B (PIB) for detection of amyloid heart deposits in hereditary transthyretin amyloidosis (ATTR)

Journal of Nuclear Cardiology, Springer 2018, Vol. 25, (1) : 240-248

Pilebro, Björn; Arvidsson, Sandra; Lindqvist, Per; et al.

Journal of the peripheral nervous system, John Wiley & Sons 2018, Vol. 23, (4) : 352-352

Polydefkis, Michael; Adams, David; Coelho, Teresa; et al.

Atrial Fibrillation and Central Nervous Complications in Liver Transplanted Hereditary Transthyretin Amyloidosis Patients

Transplantation, LIPPINCOTT WILLIAMS & WILKINS 2018, Vol. 102, (2) : e59-e66

Wange, Niklas; Anan, Intissar; Ericzon, Bo-Göran; et al.

Normal scores of deep breathing tests: beware of dysrhythmia in transthyretin amyloidosis

Amyloid: Journal of Protein Folding Disorders, Taylor & Francis Group 2018, Vol. 25, (1) : 54-61

Wiklund, Urban; Kadkhodaee, Amir; Andersson, Kennet; et al.

Management of gastrointestinal complications in hereditary transthyretin amyloidosis: a single-center experience over 40 years

Expert Review of Gastroenterology & Hepatology, Taylor & Francis 2018, Vol. 12, (1) : 73-81

Wixner, Jonas; Suhr, Ole B.; Anan, Intissar

PHASE 2 OPEN-LABEL EXTENSION (OLE) STUDY OF PATISIRAN, AN INVESTIGATIONAL RNA INTERFERENCE (RNAI) THERAPEUTIC FOR THE TREATMENT OF HEREDITARY ATTR AMYLOIDOSIS WITH POLYNEUROPATHY

Value in Health, Vol. 20, (5) : A211-A212

Adams, D.; Coelho, T.; Conceicao, E.; et al.

Phase 2 open-label extension (OLE) study of patisiran for the treatment of hereditary ATTR (hATTR) amyloidosis: 24-month safety and efficacy in subgroup of patients with cardiac involvement

European Journal of Heart Failure, WILEY 2017, Vol. 19, (Suppl: 1) : 19-19

Adams, D.; Coelho, T.; Conceicao, I.; et al.

Phase 2 open-label extension (OLE) study of patisiran with or without a TTR stabilizer for the treatment of hereditary ATTR (hATTR) amyloidosis with polyneuropathy

European Journal of Neurology, WILEY 2017, Vol. 24 : 31-32

Adams, D.; Coelho, T.; Conceicao, I.; et al.

Safety of azathioprine and 6-mercaptopurine in patients with inflammatory bowel disease naive to thiopurine treatment

International journal of clinical pharmacology and therapeutics, DUSTRI-VERLAG DR KARL FEISTLE 2017, Vol. 55, (7) : 594-600

Alaish, Ram; Lundgren, David; Suhr, Ole B.; et al.

The clinical course after glucocorticoid treatment in patients with inflammatory bowel disease is linked to suppression of the hypothalamic-pituitary-adrenal axis: a retrospective observational study

Therapeutic Advances in Gastroenterology, London: Sage Publications 2017, Vol. 10, (11) : 829-836

Ibrahim, Aghil; Dahlqvist, Per; Olsson, Tommy; et al.

Impact of genotype and phenotype on cardiac biomarkers in patients with transthyretin amyloidosis - Report from the Transthyretin Amyloidosis Outcome Survey (THAOS)

PLOS ONE, Vol. 12, (4)

Kristen, Arnt V.; Maurer, Mathew S.; Rapezzi, Claudio; et al.

EFFECT OF PATISIRAN ON NERVE FIBER DENSITY AND AMYLOID CONTENT IN SKIN: RESULTS FROM PHASE 2 OPEN LABEL EXTENSION (OLE) STUDY IN HATTR AMYLOIDOSIS

Journal of the peripheral nervous system, WILEY 2017, Vol. 22, (3) : 360-360

Polydefkis, M.; Ebenezer, G.; Adams, D.; et al.

One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition

Journal of Internal Medicine, Vol. 281, (4) : 337-347

Suhr, Ole B.; Lundgren, Erik; Westermark, P

The Swedish landscape of hereditary ATTR amyloidosis

Amyloid: Journal of Protein Folding Disorders, Vol. 24, (1) : 93-94

Suhr, Ole B; Wixner, Jonas; Pilebro, Björn; et al.

Domino liver transplantation: full-length transthyretin in donor and recipient patients with ATTR Val30Met amyloidosis

Amyloid: Journal of Protein Folding Disorders, Vol. 24 : 128-129

Westermark, Per; Nowak, Greg; Suhr, Ole B.; et al.

First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy

Current Opinion in Neurology, Lippincott Williams & Wilkins 2016, Vol. 29 : S14-S26

Adams, David; Suhr, Ole B.; Hund, Ernst; et al.

Phase 2 open-label extension study of patisiran, an investigational siRNA agent for hereditary ATTR amyloidosis with polyneuropathy (hATTR-PN)

Neuromuscular Disorders, Elsevier 2016, Vol. 26 : S142-S142

Conceicao, I.; Suhr, Ole; Coelho, T.; et al.

View publications in DiVA

Research projects

1 January 2019

Pathogenesis, diagnostics and treatment of transthyretin amyloidosis